How beneficial is the use of probiotic supplements for the aging gut?

Aging Health

Volumn 7, Issue 2, 2011, Pages 179-186

  Cusack, Siobhán ^a   Claesson, Marcus J ^a,b   O'tooL E , Paul W ^a,b  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

composition; diet; elderly; health; inflammation; intestinal microbiota; metagenome; nutrition; probiotics

Indexed keywords

PREBIOTIC AGENT; PROBIOTIC AGENT;

AGE; AGED; AGING; ARTICLE; BACTERIAL STRAIN; BIFIDOBACTERIUM; CLOSTRIDIUM DIFFICILE INFECTION; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG SAFETY; HUMAN; INTESTINE FLORA; LACTOBACILLUS; POLYPHARMACY; RISK BENEFIT ANALYSIS;

EID: 79955515697     PISSN: 1745509X     EISSN: 17455103     Source Type: Journal    
DOI: 10.2217/ahe.11.8     Document Type: Article

References (59)

1. Caley M, Sidhu K: Estimating the future healthcare costs of an aging population in the UK: expansion of morbidity and the need for preventative care. J. Public Health 33(1), 117-122 (2011).
2. Sekirov I, Russell SL, Antunes LC, Finlay BB: Gut microbiota in health and disease. PHysiol. Rev. 90(3), 859-904 (2010).
3. Woodmansey EJ: Intestinal racteria and ageing. J. Appl. Microbiol. 102(5), 1178-1186 (2007). (Pubitemid 46633436)
4. Caballero-Franco C, Keller K, De Simone C, Chadee K: The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells. Am. J. PHysiol. Gastrointest. Liver PHysiol. 292(1), G315-G322 (2007). (Pubitemid 46090273)
5. Ewaschuk JB, Diaz H, Meddings L et al.: Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function. Am. J. PHysiol. Gastrointest. Liver PHysiol. 295(5), G1025-G1034 (2008).
6. Johnson-Henry KC, Donato KA, Shen-Tu G, Gordanpour M, Sherman PM: Lactobacillus rhamnosus strain GG prevents enterohemorrhagic Escherichia coli O157:H7- induced changes in epithelial barrier function. Infect. Immun. 76(4), 1340-1348 (2008). (Pubitemid 351561979)
7. O'Toole PW, Cooney JC: Probiotic bacteria influence the composition and function of the intestinal microbiota. Interdiscip. Perspect. Infect. Dis. 2008, 175285 (2008).
8. Saulnier DM, Spinler JK, Gibson GR, Versalovic J: Mechanisms of probiosis and prebiosis: considerations for enhanced functional foods. Curr. Opin. Biotechnol. 20(2), 135-141 (2009).
9. Macfarlane S, Macfarlane GT: Regulation of short-chain fatty acid production. Proc. Nutr. Soc. 62(1), 67-72 (2003).
10. Le Blay G, Chassard C, Baltzer S, Lacroix C: Set up of a new in vitro model to study dietary fructans fermentation in formula-fed babies. Br. J. Nutr. 103(3), 403-411 (2010).
11. Mariat D, Firmesse O, Levenez F et al.: The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol. 9, 123 (2009).
12. Biagi E, Nylund L, Candela M et al.: Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS ONE 5(5), e10667 (2010).
13. Tancrede C: Role of human microflora in health and disease. Eur. J. Clin. Microbiol. Infect. Dis. 11(11), 1012-1015 (1992). (Pubitemid 23045374)
14. Petrosino JF, Highlander S, Luna RA, Gibbs RA, Versalovic J: Metagenomic pyrosequencing and microbial identification. Clin. Chem. 55(5), 856-866 (2009).
15. Tiihonen K, Ouwehand AC, Rautonen N: Human intestinal microbiota and healthy ageing. Ageing Res. Rev. 9(2), 107-116 (2010).
16. Degen LP, PHillips SF: Variability of gastrointestinal transit in healthy women and men. Gut 39(2), 299-305 (1996). (Pubitemid 26276010)
17. Moore WE, Holdeman LV: Human fecal flora: the normal flora of 20 Japanese- Hawaiians. Appl. Microbiol. 27(5), 961-979 (1974).
18. Mortensen FV, Langkilde NC, Joergensen JC, Hessov I: Short-chain fatty acids stimu|ate mucosal cell proliferation in the closed human rectum after Hartmann's procedure. Int. J. Colorectal Dis. 14(3), 150-154 (1999). (Pubitemid 29423653)
19. Comalada M, Bailon E, de Haro O et al.: The effects of short-chain fatty acids on colon epithelial proliferation and survival depend on the cellular phenotype. J. Cancer Res. Clin. Oncol. 132(8), 487-497 (2006). (Pubitemid 43938332)
20. Sokol H, Pigneur B, Watterlot L et al.: Faecalibacterium prausnitzii is an antiinflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl Acad. Sci. USA 105(43), 16731-16736 (2008).
21. Kleerebezem M, Vaughan EE: Probiotic and gut lactobacilli and bifidobacteria: molecular approaches to study diversity and activity. Annu. Rev. Microbiol. 63, 269-290 (2009).
22. Mevissen-Verhage EA, Marcelis JH, de Vos MN, Harmsen-van Amerongen WC, Verhoef J: Bifidobacterium, Bacteroides, and Clostridium spp. in fecal samples from breast-fed and bottle-fed infants with and without iron supplement. J. Clin. Microbiol. 25(2), 285-289 (1987). (Pubitemid 17232419)
23. Palmer C, Bik EM, Digiulio DB, Relman DA, Brown PO: Development of the human infant intestinal microbiota. PLoS Biol. 5(7), e177 (2007).
24. Eckburg PB, Bik EM, Bernstein CN et al.: Diversity of the human intestinal microbial flora. Science 308(5728), 1635-1638 (2005). (Pubitemid 40807514)
25. Khachatryan ZA, Ktsoyan ZA, Manukyan GP, Kelly D, Ghazaryan KA, Aminov RI: Predominant role of host genetics in controlling the composition of gut microbiota. PLoS ONE 3(8), e3064 (2008).
26. O'Toole PW, Claesson MJ: Gut microbiota: changes throughout the lifespan from infancy to elderly. Int. Dairy J. 20(4), 281-291 (2009).
27. Hopkins MJ, Sharp R, Macfarlane GT: Age and disease related changes in intestinal bacterial populations assessed by cell culture, 16S rRNA abundance, and community cellular fatty acid profiles. Gut 48(2), 198-205 (2001). (Pubitemid 32141843)
28. Claesson MJ, Cusack S, O'sullivan O et al.: Microbes and Health Sackler Colloquium: composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc. Natl Acad. Sci. USA 108(Suppl. 1), 4586-4591 (2011).
29. Mueller S, Saunier K, Hanisch C et al.: Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl. Environ. Microbiol. 72(2), 1027-1033 (2006). (Pubitemid 43271206)
30. Kalliomaki M, Antoine JM, Herz U, Rijkers GT, Wells JM, Mercenier A: Guidance for substantiating the evidence for beneficial effects of probiotics: prevention and management of allergic diseases by probiotics. J. Nutr. 140(3), 713S-721S (2010).
31. Pitkala KH, Strandberg TE, Finne Soveri UH, Ouwehand AC, Poussa T, Salminen S: Fermented cereal with specific bifidobacteria normalizes bowel movements in elderly nursing home residents. A randomized, controlled trial. J. Nutr. Health Aging 11(4), 305-311 (2007). (Pubitemid 47121927)
32. Gill HS, Rutherfurd KJ, Cross ML, Gopal PK: Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. Am. J. Clin. Nutr. 74(6), 833-839 (2001). (Pubitemid 33101806)
33. Ouwehand AC, Bergsma N, Parhiala R et al.: Bifidobacterium microbiota and parameters of immune function in elderly subjects. FEMS Immunol. Med. Microbiol. 53(1), 18-25 (2008). (Pubitemid 351659703)
34. Maukonen J, Matto J, Suihko ML, Saarela M: Intra-individual diversity and similarity of salivary and faecal microbiota. J. Med. Microbiol. 57(Pt 12), 1560-1568 (2008).
35. Makino S, Ikegami S, Kume A, Horiuchi H, Sasaki H, Orii N: Reducing the risk of infection in the elderly by dietary intake of yoghurt fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1. Br. J. Nutr. 104(7), 998-1006 (2010).
36. Mattila-Sandholm T, Myllarinen P, Crittenden R, Mogensen G, Fonden R, Saarela M: Technological challenges for future probiotic foods. Int. Dairy J. 12, 173-182 (2002). (Pubitemid 34234391)
37. Maue AC, Haynes L: CD4+ T cells and immunosenescence - a mini-review. Gerontology 55(5), 491-495 (2009).
38. Guigoz Y, Dore J, Schiffrin EJ: The inflammatory status of old age can be nurtured from the intestinal environment. Curr. Opin. Clin. Nutr. Metab. Care 11(1), 13-20 (2008). (Pubitemid 350295220)
39. Guigoz Y, Dore J, Schiffrin EJ: The inflammatory status of old age can be nurtured from the intestinal environment. Curr. Opin. Clin. Nutr. Metab. Care 11(1), 13-20 (2008). (Pubitemid 350295220)
40. He F, Ouwehand AC, Isolauri E, Hosoda M, Benno Y, Salminen S: Differences in composition and mucosal adhesion of bifidobacteria isolated from healthy adults and healthy seniors. Curr. Microbiol. 43(5), 351-354 (2001). (Pubitemid 32973287)
41. Manichanh C, Rigottier-Gois L, Bonnaud E et al.: Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 55(2), 205-211 (2006). (Pubitemid 43117279)
42. Scholz-Ahrens KE, Ade P, Marten B et al.: Prebiotics, probiotics, and synbiotics affect mineral absorption, bone mineral content, and bone structure. J. Nutr. 137(3 Suppl. 2), 838S-846S (2007). (Pubitemid 46397527)
43. Flint HJ, Duncan SH, Scott KP, Louis P: Interactions and competition within the microbial community of the human colon: links between diet and health. Environ. Microbiol. 9(5), 1101-1111 (2007). (Pubitemid 46697267)
44. van Baarlen P, Troost F, van der Meer C et al.: Microbes and health sackler colloquium: human mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathways. Proc. Natl Acad. Sci. USA 108(Suppl. 1), 4562-4569 (2011).
45. van Baarlen P, Troost FJ, van Hemert S et al.: Differential NF-kB pathways induction by Lactobacillus plantarum in the duodenum of healthy humans correlating with immune tolerance. Proc. Natl Acad. Sci. USA 106(7), 2371-2376 (2009).
46. Rijkers GT, Bengmark S, Enck P et al.: Guidance for substantiating the evidence for beneficial effects of probiotics: current status and recommendations for future research. J. Nutr. 140(3), 671S-676S (2010).
47. Hickson M, D'souza AL, Muthu N et al.: Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ 335(7610), 80 (2007).
48. Surawicz CM: Role of probiotics in antibioticassociated diarrhea, Clostridium difficileassociated diarrhea, and recurrent Clostridium difficile-associated diarrhea. J. Clin. Gastroenterol. 42(Suppl. 2), S64-S70 (2008).
49. Corr SC, Li Y, Riedel CU, O'Toole PW, Hill C, Gahan CG: Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proc. Natl Acad. Sci. USA 104(18), 7617-7621 (2007). (Pubitemid 47185955)
50. Sanders ME, Akkermans LMA, Haller D et al.: Safety assessment of probiotics for human use. Gut Microbes 1, 164-185 (2010).
51. Boyle RJ, Robins-Browne RM, Tang ML: Probiotic use in clinical practice: what are the risks? Am. J. Clin. Nutr. 83(6), 1256-1264; quiz 1446-1257 (2006). (Pubitemid 44713053)
52. Alverdy JC, Laughlin RS, Wu L: Influence of the critically ill state on host-pathogen interactions within the intestine: gut-derived sepsis redefined. Crit. Care Med. 31(2), 598-607 (2003). (Pubitemid 36232961)
53. Besselink MG, van Santvoort HC, Buskens E et al.: Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 371(9613), 651-659 (2008).
54. Bernardeau M, Guguen M, Vernoux JP: Beneficial lactobacilli in food and feed: long-term use, biodiversity and proposals for specific and realistic safety assessments. FEMS Microbiol. Rev. 30(4), 487-513 (2006). (Pubitemid 43855764)
55. Rechel B, Doyle Y, Grundy E, McKee M: How can health systems responds to population ageing? WHO and European Observatory on Health Systems and Policies, Policy Brief 10 (2009) www.euro.who.int/-data/assets/pdf- file/0004/64966/ E92560.pdf
56. Dobriansky PJ, Suzman RM: Why population aging matters: a global perspective. National Institute on Aging, National Institutes of Health, Publication number 07-6134 (2007) www.nia.nih.gov/NR/rdonlyres/9E91407ECFE8- 4903-9875-D5AA75BD1D50/0/WPAM.pdf
57. Nolte E, McKee M: Caring for people with chronic conditions: a health system perspective. WHO and European Observatory on Health Systems and Policies Series (2008) www.euro.who.int/-data/assets/pdf- file/0006/96468/E91878.pdf
58. ELDERMET project http://eldermet.ucc.ie
59. Alimentary PHarmabiotic Centre http://apc.ucc.ie